New Zealand markets closed

Renalytix Plc (RNLX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.5131-0.0758 (-12.87%)
At close: 04:00PM EDT
0.5114 -0.00 (-0.33%)
After hours: 07:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 43.00M
Enterprise value 47.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.21
Price/book (mrq)7.33
Enterprise value/revenue 21.48
Enterprise value/EBITDA -2.82

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-75.57%
S&P500 52-week change 326.49%
52-week high 34.0380
52-week low 30.2450
50-day moving average 30.7952
200-day moving average 31.1006

Share statistics

Avg vol (3-month) 3833.76k
Avg vol (10-day) 3261.88k
Shares outstanding 573.77M
Implied shares outstanding 647.55M
Float 864.97M
% held by insiders 14.85%
% held by institutions 15.53%
Shares short (30 Apr 2024) 4627.4k
Short ratio (30 Apr 2024) 42.78
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.85%
Shares short (prior month 28 Mar 2024) 4795.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,175.60%

Management effectiveness

Return on assets (ttm)-88.32%
Return on equity (ttm)-651.40%

Income statement

Revenue (ttm)2.41M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-40.50%
Gross profit (ttm)N/A
EBITDA -37.79M
Net income avi to common (ttm)-41.85M
Diluted EPS (ttm)-0.7600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.62M
Total cash per share (mrq)0.06
Total debt (mrq)8.48M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-0.08

Cash flow statement

Operating cash flow (ttm)-36.16M
Levered free cash flow (ttm)-19.77M